ARQT
USDArcutis Biotherapeutics Inc. Common Stock
$13.820+0.040 (0.290%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$13.780
High
$13.910
Low
$13.512
Volume
2.34M
Company Fundamentals
Market Cap
1.6B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.10M
Exchange
NMS
Currency
USD
52-Week Range
Low $7.86Current $13.820High $17.75
Related News
GlobeNewswire
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., July 03, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology,
View more
GlobeNewswire
Arcutis' ZORYVE® (roflumilast) Cream 0.15% Receives Strong Recommendation in American Academy of Dermatology Updated Guidelines for Adult Atopic Dermatitis
The American Academy of Dermatology (AAD) provided evidence-based recommendation for the use of ZORYVE® (roflumilast) cream 0.15% in adults with mild to moderate atopic dermatitis (AD)Recommendation reflects
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.